Related Experiment Video
Updated: Jan 13, 2026

Author Spotlight: Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome
Published on: May 26, 2023
When the Numbers Lie: Uncovering Pseudohyponatremia After an Anabolic Steroid Injection
Danielle C Lacasse1, Ashley M Otto1, Nathan Bosse1
1Internal Medicine, Naval Medical Center Portsmouth, Portsmouth, USA.
Abstract:
Pseudohyponatremia is a laboratory artifact in which serum sodium levels appear falsely low despite normal serum osmolality. It typically occurs in the presence of hypertriglyceridemia or paraproteinemia, but this case highlights a rare etiology: inadvertent intravenous injection of an oil-diluted anabolic steroid. A 42-year-old healthy man presented to the emergency department with nausea, vomiting, and presyncope. He reported injecting trenbolone intramuscularly three days prior and noted blood aspiration before injection, suggesting possible intravenous administration. He denied other recent illnesses or exposures. On examination, he was afebrile, hemodynamically stable, and non-toxic, with an unremarkable physical exam. Initial laboratory results revealed a serum sodium level of 125 mmol/L. However, the measured serum osmolality was 289 mOsm/kg while the calculated osmolality was 259 mOsm/kg, revealing an osmolal gap. A point-of-care iSTAT revealed a sodium level of 137 mmol/L, indicating true normonatremia and supporting the diagnosis of pseudohyponatremia. Additional labs showed erythrocytosis, consistent with anabolic steroid use, and no evidence of hypertriglyceridemia or paraproteinemia. Nephrology was consulted due to concern for symptomatic hyponatremia. With a normal measured osmolality, normal lipid and protein levels, and a history of recent anabolic steroid injection, the low serum sodium level was attributed to a laboratory artifact resulting from nonaqueous solvent interference. The patient was admitted for observation and remained stable, with improving symptoms and normalizing labs. Serum sodium by main-lab indirect analysis was 136 mmol/L by the time of discharge on hospital day two. He was discharged with outpatient follow-up. In patients with unexplained hyponatremia and normal clinical status, pseudohyponatremia must be considered. Prompt recognition can prevent unnecessary treatments, reduce patient risk, and guide appropriate care.
More Related Videos
07:38Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
12:04Human Neuroendocrine Tumor Cell Lines as a Three-Dimensional Model for the Study of Human Neuroendocrine Tumor Therapy
Published on: August 14, 2012
Related Concept Videos
Prevention of Further Absorption of Poison
Antihypertensive Drugs: Potassium-Sparing Diuretics
Enhanced Elimination of Poison
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Hypoglycemia and Glucagon
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome I : Introduction